NO934499D0 - Ikke-klorfluorcarbonaerosolformuleringer - Google Patents

Ikke-klorfluorcarbonaerosolformuleringer

Info

Publication number
NO934499D0
NO934499D0 NO934499D NO934499D NO934499D0 NO 934499 D0 NO934499 D0 NO 934499D0 NO 934499 D NO934499 D NO 934499D NO 934499 D NO934499 D NO 934499D NO 934499 D0 NO934499 D0 NO 934499D0
Authority
NO
Norway
Prior art keywords
fatty acid
klorfluorcarbonaerosolformuleringer
tetrafluoroethane
propellant
excipient
Prior art date
Application number
NO934499D
Other languages
English (en)
Inventor
Julianne Fassberg
Joel A Sequeira
Imtiaz A Chaudry
Michael Kopcha
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24863572&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO934499(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO934499D0 publication Critical patent/NO934499D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols
NO934499D 1991-06-10 1993-12-09 Ikke-klorfluorcarbonaerosolformuleringer NO934499D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71278991A 1991-06-10 1991-06-10
PCT/US1992/004618 WO1992022287A1 (en) 1991-06-10 1992-06-08 Non-chlorofluorocarbon aerosol formulations

Publications (1)

Publication Number Publication Date
NO934499D0 true NO934499D0 (no) 1993-12-09

Family

ID=24863572

Family Applications (2)

Application Number Title Priority Date Filing Date
NO934499D NO934499D0 (no) 1991-06-10 1993-12-09 Ikke-klorfluorcarbonaerosolformuleringer
NO934499A NO934499L (no) 1991-06-10 1993-12-09 Ikke-klorfluorcarbonaerosolformuleringer

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO934499A NO934499L (no) 1991-06-10 1993-12-09 Ikke-klorfluorcarbonaerosolformuleringer

Country Status (24)

Country Link
US (2) US6503482B1 (no)
EP (7) EP0653205B1 (no)
JP (1) JPH06508149A (no)
CN (1) CN1067579A (no)
AT (4) ATE226067T1 (no)
AU (1) AU2178992A (no)
CA (1) CA2111003A1 (no)
CZ (1) CZ271393A3 (no)
DE (4) DE69232818T2 (no)
DK (1) DK1277467T3 (no)
ES (3) ES2180592T3 (no)
FI (1) FI935463A (no)
HU (1) HUT67445A (no)
IE (1) IE921848A1 (no)
IL (1) IL102130A0 (no)
MX (1) MX9202751A (no)
NO (2) NO934499D0 (no)
NZ (1) NZ243062A (no)
OA (1) OA09827A (no)
PT (1) PT1277467E (no)
SK (1) SK140593A3 (no)
WO (1) WO1992022287A1 (no)
YU (1) YU59192A (no)
ZA (1) ZA924163B (no)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
CA2125666C (en) 1991-12-12 2002-07-16 Rachel Ann Akehurst Medicaments
ES2079210T3 (es) * 1991-12-12 1996-01-01 Glaxo Group Ltd Formulacion farmaceutica de aerosol.
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US20030103907A1 (en) * 1991-12-18 2003-06-05 Schultz Robert K. Suspension aerosol formulations
DE69233319T2 (de) 1991-12-18 2005-02-17 Minnesota Mining & Manufacturing Company, St. Paul Aerosolzusammensetzungen für Arzneimittelsuspensionen
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
AU699677B2 (en) * 1992-07-31 1998-12-10 Glaxo Group Limited Surfactant free aerosol formulations containing beclomathasone dipropionate
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
US5833950A (en) * 1992-07-31 1998-11-10 Glaxo Group Limited Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
DE4322703A1 (de) * 1993-07-08 1995-01-12 Asta Medica Ag Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
PT735884E (pt) * 1993-12-20 2000-09-29 Minnesota Mining & Mfg Formulacoes de aerossol de flunisolida
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
JPH09510445A (ja) * 1994-03-14 1997-10-21 アボツト・ラボラトリーズ ビタミンｅ含有エアゾル医薬組成物
GB9405594D0 (en) * 1994-03-22 1994-05-11 Ici Plc Cooling compositions
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
JP4155594B2 (ja) * 1994-12-22 2008-09-24 アストラゼネカ・アクチエボラーグ エアゾール製剤
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
DE19616573C2 (de) 1996-04-25 1999-03-04 Pari Gmbh Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
US5962445A (en) * 1996-05-09 1999-10-05 Amrad Operations Pty Ltd. Treatment of asthma and airway diseases
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
AU719079B2 (en) * 1996-08-29 2000-05-04 Merck Sharp & Dohme Corp. Chlorofluorocarbon-free mometasone furoate aerosol formulations
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
EP1011646B1 (en) * 1996-12-04 2005-08-17 Link Products Limited Pharmaceutical compositions and devices for their administration
EP0966958A4 (en) * 1997-03-14 2001-10-10 Fujisawa Pharmaceutical Co AEROSOL PREPARATION
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
GB2326334A (en) † 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
CA2305256C (en) * 1997-10-09 2005-05-17 Schering Corporation Mometasone furoate suspensions for nebulization
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
MXPA02001323A (es) 2000-05-10 2004-07-16 Alliance Pharma Microgranulos con base fosfolipida para la liberacion de farmaco.
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
CA2468958C (en) 2001-12-19 2012-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
DE60318727T2 (de) * 2002-08-27 2009-01-08 Schering Corp. Verfahren zur herstellung von dosierinhalatorformulierungen
CN1708778B (zh) 2002-10-31 2012-05-02 株式会社半导体能源研究所 显示设备及其控制方法
JP4570960B2 (ja) * 2002-12-10 2010-10-27 セプラコール・インコーポレイテッド レバルブテロール塩
WO2005025506A2 (en) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
MXPA06004331A (es) * 2003-10-20 2006-06-05 Schering Corp Composiciones farmaceuticas.
US20050186144A1 (en) * 2004-01-21 2005-08-25 Schering Corporation Treatment methods
PL2486942T3 (pl) 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
WO2007020204A2 (en) * 2005-08-12 2007-02-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
WO2007095039A2 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
CN100446770C (zh) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 丙酸培氯米松水雾剂
CN104188907A (zh) * 2007-02-11 2014-12-10 Map药物公司 治疗性施用dhe用于快速减轻偏头痛而使副作用分布最小化的方法
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid
US20110171141A1 (en) * 2009-06-26 2011-07-14 Kellerman Donald J Administration of dihydroergotamine mesylate particles using a metered dose inhaler
JP6374682B2 (ja) * 2013-09-09 2018-08-15 花王株式会社 筋萎縮抑制剤
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
AU2019285374A1 (en) * 2018-06-13 2021-01-28 Puff-Ah Pty Ltd Apparatus for use in delivering respiratory drugs

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (no) 1956-03-21 1900-01-01
US2885427A (en) 1956-11-15 1959-05-05 Dow Chemical Co Fluorination of trichloroethylene
US3320125A (en) 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
US3261748A (en) 1964-07-17 1966-07-19 Dow Chemical Co 1,1,1,2-tetrafluoroethane anesthetic
GB1200886A (en) 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
NL7708731A (nl) 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US4129603A (en) 1978-02-07 1978-12-12 Imperial Chemical Industries Limited Manufacture of halogenated compounds
US4311863A (en) 1980-06-11 1982-01-19 E. I. Du Pont De Nemours & Company Process for the manufacture of 1,1,1,2-tetrafluoroethane
EP0057401B1 (en) 1981-02-02 1984-08-01 Schering Corporation Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
DE3246081A1 (de) * 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
ES2038696T3 (es) * 1986-03-10 1996-07-16 Burghart Kurt Procedimiento para producir un preparado farmaceutico.
US4851595A (en) 1987-07-07 1989-07-25 E. I. Du Pont De Nemours And Company Liquid phase halogen exchange process for the manufacture of 1,1,1,2-tetrafluoroethane
US4967024A (en) 1988-06-23 1990-10-30 E. I. Du Pont De Nemours And Company Catalyzed hydrofluorination process
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828544D0 (en) 1988-12-07 1989-01-11 Ici Plc Chemical process
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
DE3905726A1 (de) 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
GB8908250D0 (en) * 1989-04-12 1989-05-24 Fisons Plc Formulations
AU633584B2 (en) 1989-06-15 1993-02-04 Tokyo Tanabe Company Limited Aerosols of pyrido(1,2-a)pyrimidine compounds
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
ES2071306T3 (es) 1990-03-23 1995-06-16 Minnesota Mining & Mfg El uso de tensioactivos fluorados solubles para la preparacion de formulaciones aerosoles dosificadas.
AU650463B2 (en) * 1990-06-27 1994-06-23 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
IL98639A0 (en) * 1990-06-28 1992-07-15 Glaxo Inc Aerosol drug formulations
CA2085884C (en) * 1990-06-29 2001-12-04 Asit Somani Pressurized hydrofluorocarbon aerosol compositions
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
DE4038203A1 (de) * 1990-11-30 1992-06-04 Kali Chemie Pharma Gmbh Pharmazeutische spray-zubereitungen mit coronaraktiven wirkstoffen
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DK0656206T3 (da) * 1991-06-10 2001-10-08 Schering Corp Aerosolformuleringer uden chlorfluorcarbonforbindelser
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5736124A (en) 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
CA2125666C (en) 1991-12-12 2002-07-16 Rachel Ann Akehurst Medicaments
DE69233319T2 (de) 1991-12-18 2005-02-17 Minnesota Mining & Manufacturing Company, St. Paul Aerosolzusammensetzungen für Arzneimittelsuspensionen
US5202110A (en) * 1992-01-22 1993-04-13 Virginia Commonwealth University Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants

Also Published As

Publication number Publication date
US6503482B1 (en) 2003-01-07
EP0587790B1 (en) 1996-01-03
ZA924163B (en) 1993-02-24
EP0587790B2 (en) 2000-03-08
IE921848A1 (en) 1992-12-16
CA2111003A1 (en) 1992-12-23
US6416743B1 (en) 2002-07-09
EP1277467A3 (en) 2003-04-16
ES2158908T3 (es) 2001-09-16
IL102130A0 (en) 1993-01-14
EP0518601A1 (en) 1992-12-16
EP0656205A1 (en) 1995-06-07
CN1067579A (zh) 1993-01-06
DE69233659T2 (de) 2007-09-13
AU2178992A (en) 1993-01-12
PT1277467E (pt) 2006-12-29
FI935463A0 (fi) 1993-12-07
ATE226067T1 (de) 2002-11-15
DE69232818D1 (de) 2002-11-21
EP0656205B1 (en) 2001-08-08
DE69233659D1 (de) 2006-11-02
NZ243062A (en) 1993-09-27
EP1736147A3 (en) 2007-10-17
JPH06508149A (ja) 1994-09-14
EP0587790A1 (en) 1994-03-23
ATE132368T1 (de) 1996-01-15
YU59192A (sh) 1994-12-28
DE69231991D1 (de) 2001-09-13
EP1277467A2 (en) 2003-01-22
ATE203900T1 (de) 2001-08-15
SK140593A3 (en) 1994-11-09
OA09827A (en) 1994-04-15
EP1736147A2 (en) 2006-12-27
DE69232818T2 (de) 2003-06-18
WO1992022287A1 (en) 1992-12-23
FI935463A (fi) 1993-12-07
EP0653205B1 (en) 2002-10-16
HUT67445A (en) 1995-04-28
NO934499L (no) 1993-12-09
ES2180592T3 (es) 2003-02-16
EP0653205A1 (en) 1995-05-17
EP1277467B1 (en) 2006-09-20
ES2269582T3 (es) 2007-04-01
ATE339952T1 (de) 2006-10-15
DE69207409D1 (de) 1996-02-15
EP1005860A1 (en) 2000-06-07
MX9202751A (es) 1992-12-01
DK1277467T3 (da) 2007-01-15
CZ271393A3 (en) 1994-07-13
DE69231991T2 (de) 2002-04-04

Similar Documents

Publication Publication Date Title
FI935463A (fi) Klorfluorkolfria aerosolformulationer
PH30120A (en) Stable pharmaceutical composition of fumagillol derivatives
ES2064160T3 (es) Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
DE3767615D1 (de) Pharmazeutikum sowie verfahren zu seiner herstellung.
DE69316760D1 (de) Oberflächenaktivmittelfreie aerosolformulierungen enthaltend beclomethason dipropionat
HU896123D0 (en) Pharmaceutical compositions
DK0657164T3 (da) Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid
ATE117200T1 (de) Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit.
SE8104657L (sv) Injicerbara farmaceutiska kompositioner
JPS53112835A (en) Novel hydroxybenzoic ester and antiseptic agent containing the same as effective ingredient
CA2141039A1 (en) Surfactant free aerosol formulations containing beclomethasone dipropionate